跳至主要内容
临床试验/NL-OMON38586
NL-OMON38586已完成4 期

Immunological response to Hepatitis B vaccination in obsessive compulsive disorder patients receiving high doses of serotonin reuptake inhibitors - Hepatitis B vaccination in SRI-treated OCD patients

Academisch Medisch Centrum0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Primary diagnosis: obsessive compulsive disorder according to DSM-IV criteria based on a psychiatric interview
  • Age: 18-40 years old
  • Body mass index (BMI) < 25
  • Treated with 60 mg/d paroxetine (group 1) or not taking any serotonergic medication (group 2)
  • Written informed consent
  • Dutch or English speaking and able to answer the study questions
  • Capable to make his or her own choice without coercion

排除标准

  • Previous hepatitis B vaccination or hepatitis B infection
  • Suffering from auto-immune disease such as rheumatoid arthritis, lupus erythematosus etc.
  • A weakened immune system, due to conditions such as HIV
  • Kidney and/or liver diseases
  • The use of immunosuppressive medication such as corticosteroids, methotrexate, cyclosporine

研究者

相似试验